Clinical Trial Update: Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy [Phase 3]

View source ↗

Summary

This document reports a Phase 3 effect observation trial evaluating a COX-2 inhibitor for Primary Hypertrophic Osteoarthropathy, with the trial status currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Osteoarthropathy

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Hypertrophic Osteoarthropathy | Phase 3 | Status: UNKNOWN